ARCHIVES

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Strict System For Protection Of Human Subjects Ordered In Wake Of NIH Investigation

August 9, 1991

Van Nevel New NCI information Chief: Karel Leaves For Johnson Foundation

August 30, 1974

ACS Unveils Plan For Combating Tobacco Marketing

May 18, 1990

60-Mile Limit For Primate Facility Dropped

June 9, 1978

ASCO Calls For New Clinical Study Section, Endorses NCAB Action In Senate Testimony

July 23, 1993

Obituary: Rajka Medenica, controversial Physician

December 5, 1997